云南高校图书馆联盟文献共享服务平台- METABOLIC

METABOLIC_SYNDROME: 作品数：656被引量：2568H指数：22; 导出分析报告; 相关作者：林波徐成斌米杰梁亚军秦秀娟更多>>; 相关机构：浙江省人民医院福建医科大学北京大学首都儿科研究所更多>>; 相关期刊：更多>>; 相关基金：国家自然科学基金国家重点基础研究发展计划国家科技支撑计划北京市自然科学基金更多>>

Comparisons of various insulin resistance indices for new-onset metabolic syndrome before midlife:The CHIEF cohort study,2014-2020: 《World Journal of Diabetes》2025年第5期192-201,共10页Wei-Nung Liu Yi-Chiung Hsu Yen-Po Lin Kun-Zhe Tsai Yen-Chen Lin Pang-Yen Liu Gen-Min Lin; Supported by Medical Affairs Bureau Ministry of National Defense,No.MND-MAB-D-114222;Hualien Armed Forces General Hospital,No.HAFGH-D-114008.; BACKGROUND Some non-insulin-based insulin resistance(IR)indices have been found to be associated with metabolic syndrome(MetS);however,few cohort studies have compared the capacities of these indices for predicting in...; 关键词：Cohort study Insulin resistance indices Metabolic syndrome Young adults

New therapy for metabolic syndrome:Gut microbiome supplementation被引量：1: 《World Journal of Diabetes》2024年第9期1833-1836,共4页Waseem Qureshi Maqsood Ahmad Dar Mohd Younis Rather; The gut microbiota is important in the development and progression of metabolic illnesses such type 2 diabetes,cardiovascular disease(CVD),and obesity.This diverse community of microorganisms controls a variety of phy...; 关键词：PROBIOTICS PREBIOTICS SYNBIOTICS Postbiotics MICROBIOME Type 2 diabetes mellitus Cardiovascular disease Obesity

Adiposity in Chinese people with type 1 diabetes: 《World Journal of Diabetes》2024年第7期1404-1408,共5页Nian-Wei Wu Xia-Fei Lyu Zhen-Mei An She-Yu Li; Supported by 1.3.5 Project for Disciplines of Excellence,West China Hospital,Sichuan University,No.ZYYC24001.; Adiposity,synonymous with obesity,is prevalent among both children and adults with type 1 diabetes in China.Recent literature underscored the pathophysiological and socioeconomic factors associated with adiposity,and ...; 关键词：Type 1 diabetes China Metabolic syndrome OBESITY Anti-obesity medications

Insulin resistance as the molecular link between diabetes and Alzheimer's disease被引量：2: 《World Journal of Diabetes》2024年第7期1430-1447,共18页Mona Mohamed Ibrahim Abdalla; Diabetes mellitus(DM)and Alzheimer's disease(AD)are two major health concerns that have seen a rising prevalence worldwide.Recent studies have indicated a possible link between DM and an increased risk of developing A...; 关键词：Alzheimer's disease Insulin resistance OBESITY DEMENTIA DIABETES Metabolic syndrome

Drawing lines in the sand: The growing threat of obesity in type 1 diabetes: 《World Journal of Diabetes》2024年第5期823-827,共5页Theocharis Koufakis Dimitrios Patoulias Ioanna Zografou Nikolaos Papanas Djordje S Popovic; In this editorial,we comment on the article by Zeng et al published in the recent issue of the World Journal of Diabetes in 2024.We focus on the epidemiological,pathophysiological,and clinical interplay between obesit...; 关键词：OBESITY OVERWEIGHT Type 1 diabetes Metabolic syndrome

Metabolic syndrome’s new therapy:Supplement the gut microbiome被引量：1: 《World Journal of Diabetes》2024年第4期793-796,共4页Yong-Wei Xu Jun Tian Yan Song Ba-Cui Zhang Jing Wang; Supported by the Songjiang District Tackling Key Science and Technology Research Projects,No.20sjkjgg32;the Excellent Young Talents Training Program of Songjiang Hospital Affiliated with Shanghai Jiao Tong University School of Medicine,No.QNRC-004;Science and Technology Project of Songjiang District,No.22SJKJGG81。; This letter to the editor discusses the publication on gut microbiome supple-mentation as therapy for metabolic syndrome.Gut microbiome dysbiosis disrupts intestinal bacterial homeostasis and is related to chronic inf...; 关键词：Gut microbiome Metabolic syndrome Diabetes mellitus Short-chain fatty acids Chronic liver disease

Practical guide:Glucagon-like peptide-1 and dual glucosedependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonists in diabetes mellitus被引量：1: 《World Journal of Diabetes》2024年第3期331-347,共17页Saleh Fahad Alqifari Omar Alkomi Abdullah Esmail Khadijeh Alkhawami Shahd Yousri Mohamad Ayham Muqresh Nawwarah Alharbi Abdullah A Khojah Ahmed Aljabri Abdulrahman Allahham Kousalya Prabahar Hanan Alshareef Mohammed Aldhaeefi Tariq Alrasheed Ali Alrabiah Laila A AlBishi; Practical guide:Glucagon-like peptide-1 and dual glucosedependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonists in diabetes mellitus common second-line choice after metformin for treating T2...; 关键词：Glucagon-like peptide-1 receptor agonist Diabetes mellitus Metabolic syndrome Dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonist Clinical practice ENDOCRINOLOGY

Body composition and metabolic syndrome in patients with type 1 diabetes被引量：3: 《World Journal of Diabetes》2024年第1期81-91,共11页Qiong Zeng Xiao-Jing Chen Yi-Ting He Ze-Ming Ma Yi-Xi Wu Kun Lin; Supported by the“SDF-sweet doctor cultivation”Project of Sinocare Diabetes Foundation,No.2022SD11 and No.2021SD09.; BACKGROUND In recent years,the prevalence of obesity and metabolic syndrome in type 1 diabetes(T1DM)patients has gradually increased.Insulin resistance in T1DM deserves attention.It is necessary to clarify the relatio...; 关键词：Body composition Metabolic syndrome Insulin resistance Visceral fat Estimated glucose disposal rate

Gut microbiome supplementation as therapy for metabolic syndrome被引量：3: 《World Journal of Diabetes》2023年第10期1502-1513,共12页Mc Anto Antony Aniqa Chowdhury Dinesh Edem Rishi Raj Priyanshu Nain Mansi Joglekar Vipin Verma Ravi Kant; The gut microbiome is defined as an ecological community of commensal symbiotic and pathogenic microorganisms that exist in our body.Gut microbiome dysbiosis is a condition of dysregulated and disrupted intestinal bac...; 关键词：Gut dysbiosis Metabolic syndrome Diabetes mellitus PREBIOTICS PROBIOTICS Postbiotics

Improved systemic half-life of glucagon-like peptide-1-loaded carbonate apatite nanoparticles in rats: 《World Journal of Diabetes》2022年第8期613-621,共9页Nabilah Ibnat Rahela Zaman Mohammad Borhan Uddin Ezharul Chowdhury Chooi Yeng Lee; Supported by an FRGS grant from the Ministry of Education,Malaysia,No.FRGS/2/2014/SG05/MUSM/03/1.; BACKGROUND Glucagon-like peptide-1(GLP1)is an endogenous peptide that regulates blood glucose level.But its susceptibility to rapid metabolic degradation limits its therapeutic use.AIM To prepare GLP1-encapsulated nan...; 关键词：Glucagon-like peptide-1 Metabolic syndrome NANOPARTICLES Plasma half-life RAT

METABOLIC_SYNDROME